Introducing our highly effective Anti-HSV gD/Envelope glycoprotein D Antibody (E317) – the perfect solution for your biotech research needs.
This innovative antibody is specifically designed to target the glycoprotein D (gD) of the herpes simplex virus (HSV), making it a valuable tool for studying the virus and its interactions with host cells.
The main function of our Anti-HSV gD/Envelope glycoprotein D Antibody (E317) is to inhibit the binding of gD to its host cell receptors, thereby preventing viral entry and replication. This makes it an ideal choice for studying the mechanism of HSV infection and developing potential antiviral therapies.
With its high specificity and affinity, our antibody is suitable for a wide range of applications, including immunofluorescence, western blotting, and ELISA. It has been extensively validated in various cell lines and has shown excellent results in detecting gD in both infected and uninfected cells.
Our Anti-HSV gD/Envelope glycoprotein D Antibody (E317) has been used in numerous research studies, with promising results. It has been shown to effectively block viral entry and reduce viral replication in vitro, making it a valuable tool for understanding the pathogenesis of HSV and developing new treatments.
In addition to its research applications, our antibody can also be used in diagnostic assays for detecting HSV infections. Its high sensitivity and specificity make it a reliable tool for identifying and differentiating between HSV strains.
Don’t miss out on the opportunity to enhance your biotech research with our Anti-HSV gD/Envelope glycoprotein D Antibody (E317). Order now and discover its full potential in unraveling the mysteries of HSV and developing effective treatments.
There are no reviews yet.